Showing results (11-20 of 210) with videos related to
Sort By:
Pageof 21
European Journal of Preventive Cardiology|January 31, 2015
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-CMichael J Pencina, Ralph B D'Agostino, Tomasz Zdrojewski, et al.Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Withdrawal of cerivastatin from the world marketCurt D Furberg, Bertram PittThe American Journal of Cardiology|November 7, 2002
How, when, and why to use apolipoprotein B in clinical practiceAllan D SnidermanJournal of Clinical Lipidology|February 5, 2011
Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practiceAllan D SnidermanCurrent Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Low-density lipoprotein lowering in type 2 diabetes mellitus: how to know how low to goAllan D SnidermanThe American Journal of Cardiology|November 3, 2004
Is there value in liver function test and creatine phosphokinase monitoring with statin use?Allan D SnidermanCurrent Opinion in Lipidology|July 10, 2004
Applying apoB to the diagnosis and therapy of the atherogenic dyslipoproteinemias: a clinical diagnostic algorithmAllan D SnidermanDrug Safety|November 20, 2016
The Harms of Antipsychotic Drugs: Evidence from Key StudiesThomas J Moore, Curt D FurbergDrug Safety|May 31, 2015
Electronic Health Data for Postmarket Surveillance: A Vision Not RealizedThomas J Moore, Curt D FurbergPageof 21